NEW YORK – In the pursuit of new genetic targets for lung cancer treatments, researchers at Pfizer have teamed up with Boston Children's Hospital, genetic research company Citizen Genetics, and Inspire, a social network for patients and caregivers, to recruit difficult-to-find patients who may have a genetic resilience to the disease.
Pfizer Turns to Health Social Network to Find Patients With Rare Lung Cancer Genetic Variants
Premium
Get the full story with
Premium Access
Only $95 for the
first 90 days*
Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.